MSR1 was highly expressed, with a statistically significant difference in some tumors, including glioblastoma (GBM), kidney renal cell carcinoma (KIRC), breast cancer (BRCA), pancreatic adenocarcinoma (PAAD), ovarian carcinoma (OV), stomach adenocarcinoma (STAD), skin cutaneous melanoma (SKCM) and esophagus carcinoma (ESCA), among others (Figure 1A,B). Here, MSR1 is linked to cutaneous melanoma.